Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for moderate traumatic brain injury in ICU patients
IRCT20190725044331N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in traumatic brain injury (TBI) comparing N-acetylcysteine with Placebo (2 arms). Primary endpoints: Change in consciousness level, Duration of hospitalization and 2 more. Started Aug 2019; status: completed.
02
Drugs
acetylcysteine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20190725044331N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190725044331N1.